Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire January 02, 2026 FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of January 1, 2026 equity inducement awards to two […]
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference GlobeNewswire January 02, 2026 ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight's management
Horizon Bancorp, Inc. Announces Conference Call to Review Fourth Quarter Results on January 22 GlobeNewswire January 02, 2026 MICHIGAN CITY, Ind., Jan. 02, 2026 (GLOBE NEWSWIRE) — Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m. CT on Thursday, January 22, 2026, to review its fourth quarter 2025 financial
(NASDAQ:GMGI), VALLETTA, Malta, Jan. 02, 2026 (GLOBE NEWSWIRE) — Meridianbet, the sports betting and gaming operator and subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), today announced that CEO Zoran Milosevic was featured in an in-depth profile published by The Jerusalem Post, one of the world's leading international news organizations. The profile, titled “From gaming
Meridianbet (GMGI) CEO Featured in Jerusalem Post: “We Are Not a Promise-Based Company, We Are an Execution-Based Company” GlobeNewswire January 02, 2026 VALLETTA, Malta, Jan. 02, 2026 (GLOBE NEWSWIRE) — Meridianbet, the sports betting and gaming operator and subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), today announced that CEO Zoran Milosevic was featured in
(NasdaqGM:GHRS), DUBLIN, Jan. 02, 2026 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported that it will provide an update on the status of its Investigational New Drug Application (IND) for GH001 with the U.S. Food
(NasdaqGM:NTLA), CAMBRIDGE, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on January 1, 2026, it awarded inducement grants to two new employees under Intellia's 2024 Inducement Plan as a material inducement to employment. The inducement grants
(NASDAQ:OZK),(NASDAQ:OZKAP), LITTLE ROCK, Ark., Jan. 02, 2026 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors declared a quarterly cash dividend on the Bank's common stock of $0.46 per share, up $0.01, or 2.22% from the prior quarter. The common stock dividend is payable on January 20, 2026, to shareholders
(NASDAQ:FORM), LIVERMORE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 28th Annual Needham Growth Conference on January 13th and 14th, 2026. FormFactor is scheduled to present on Tuesday, January 13th at 3:00PM ET. The company's Chief Execute Officer, Michael Slessor, will present. The public
(NASDAQ:HOFT), Enters Cooperation Agreement with GVIC Announces Retirement of Board Chair Chris Beeler at 2026 Annual Meeting Following 33 Years of Service to Hooker MARTINSVILLE, Va., Jan. 02, 2026 (GLOBE NEWSWIRE) — Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (“Hooker” or the “Company”), a global leader in home furnishings, today announced it has entered into a cooperation